LPCN

Lipocine Inc. - Common Stock (LPCN)

About Lipocine Inc. - Common Stock (LPCN)

Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of the delivery of drugs using proprietary delivery technology. It offers TLANDO, an oral testosterone replacement therapy. The company was founded on October 13, 2011 and is headquartered in Salt Lake City, UT.

Details

Daily high

$3.28

Daily low

$3.14

Price at open

$3.15

52 Week High

$5.50

52 Week Low

$2.52

Market cap

17.5M

Dividend yield

0.00%

Volume

18,902

Avg. volume

48,523

P/E ratio

-3.10

Lipocine Inc. - Common Stock News